Preclinical validation of the small molecule drug quininib as a novel therapeutic for colorectal cancer.
about
Vitamin D receptor agonists regulate ocular developmental angiogenesis and modulate expression of dre-miR-21 and VEGF.A Quininib Analogue and Cysteinyl Leukotriene Receptor Antagonist Inhibits Vascular Endothelial Growth Factor (VEGF)-independent Angiogenesis and Exerts an Additive Antiangiogenic Response with Bevacizumab.Emerging Estrogenic Pollutants in the Aquatic Environment and Breast Cancer.Store-Operated Ca2+ Entry as a Prostate Cancer Biomarker — a Riddle with Perspectives.
P2860
Preclinical validation of the small molecule drug quininib as a novel therapeutic for colorectal cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Preclinical validation of the ...... apeutic for colorectal cancer.
@en
type
label
Preclinical validation of the ...... apeutic for colorectal cancer.
@en
prefLabel
Preclinical validation of the ...... apeutic for colorectal cancer.
@en
P2093
P2860
P50
P356
P1433
P1476
Preclinical validation of the ...... rapeutic for colorectal cancer
@en
P2093
Adrian G Murphy
Aoife Maguire
Clare T Butler
David Fennelly
Diarmuid O'Donoghue
Kieran Sheahan
Miriam Tosetto
Rory Casey
P2860
P2888
P356
10.1038/SREP34523
P407
P577
2016-10-14T00:00:00Z